I have been sick with type 2 diebetic problems since 1997 and I just started to use cbd oil in a vape pen in 2018 I found that it really works well for controlling severe foot nerve pain and I can stop with the symbalta for nerve pain that has very bad side effects on me I also have hart problems with 2 stents put in I don’t know yet what will happen with the hart issues but waiting to see I do know I have been a calmer person not as aggressive like I used to be with less stress and pain and hyper aggressive violent attitude has went way down which was one of the symbalta side affects since I’m not depressed which what symbalta was made for but works also for nerve pain for diebetics but for me has reversed affects and makes me depressed and bad tude so all in all I’m sticking with the cbd oil I don’t know about future affects from use but like everything else theres al ways some kind of affect but I’m thinking this way is still better than hands full of pills every day that damage your liver and kidneys I’m not saying to stop your meds just the few that become not needed and replaced by the oil still have to take my shots to control sugar maybe one day big pharma will let the cure out but I will not hold my breath on that one haha so far so good have to see what the future brings take care all and do your research john
How does CBD oil work? CBD interacts with the endocannabinoid system in your body. How taking CBD oil for weight loss works involves this system. CBD stimulates different components in your body to help your body break down more fat, it helps burn more calories all the way down to the cellular level, decreases lipid production, suppresses appetite, and increases your metabolism. Currently, there is still a lot to learn about CBD and weight loss, but the results we’ve seen for far go to show that this is a great option for anyone who needs weight loss help.
Our bodies are thought to produce endocannabinoids by the billions every day. “We always thought the ‘runner’s high’ was due to the release of dopamine and endorphins. But now we know the euphoria is also from an endocannabinoid called anandamide,” its name derived from the Sanskrit word for bliss, says Joseph Maroon, MD, clinical professor and vice chairman of neurosurgery at the University of Pittsburgh Medical Center. We produce these natural chemicals all day, but they fade quickly because enzymes pop up to destroy them. That’s where CBD comes in: By blocking these enzymes, CBD allows the beneficial compounds to linger.

The current trend in the cannabis-related area of research started in the late sixties and early seventies when products derived from cannabis (especially marijuana) were placed on the list of controlled substances in the US, under the Nixon administration. This move was retroactively interpreted as being part of the conservative reaction to the liberalizing spirit of the sixties. 

The previously mentioned study which established improved mitochondrial function with CBD use also observed that CBD stimulates gene expression within white fat cells. This initiates the “browning” of these cells. This mechanism shows promise with converting hard-to-lose white fat into a more easily burnable form. Additionally, researchers found that CBD decreased the rate of new fat cell creation.

The inquiry upon the manner in which THC produces its psychoactive effects on the human body led, in the 1980’s, to the discovery of the endocannabinoid system – a rather loose complex of nerve receptors which under the influence of compounds called cannabinoids trigger many physiological and psychological reactions. Because cannabinoid receptors are present in almost every tissue of a mammal’s body (although they are not limited to mammals), it has wide-ranging influences on the well-being of an organism. Therefore cannabinoids are definitely substances that deserve further attention from scientists.
As one might expect from the information presented in the previous sections of this article, the position of cannabidiol (both from a medical and from an institutional point of view) is one of uncertainty. To add insult to injury, private companies (especially those targeting immediate profit with a minimum of investment) take advantage of the loopholes in legislation to gain from the media exposure that CBD has had in the past few years.
More recent experiments, involving the administration of a part CBD part THC solution, have yielded results that contradict the first supposition. At present, on the evidence that cannabidiol reduces some of the psychoactive effects of tetrahydrocannabinol (acting as a de facto antidepressant), scientists argue that cannabidiol has a holistic but indirect influence on all cannabinoid receptors in the endocannabinoid system. The main consequence of this impact seems to be an increase in the production of endocannabinoids. This is now the prevailing idea that accounts for the mountains of empirical evidence of how the benefits of cannabidiol are expressed at the cellular level.
×